Anti-prothrombin antibodies assay in patients with a risk of thrombosis

被引：0
|
作者：
Gaudrat, F
Desse, D
Coude, M
Pineau-Vincent, F
机构：
来源：
ANNALES DE BIOLOGIE CLINIQUE | 2005年 / 63卷 / 06期
关键词：
antiprothrombin antibodies; ELISA assay; thrombosis;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：671 / 672
页数：2
相关论文
共 50 条
  • [31] Antiphosphatidylserine/prothrombin antibodies (aPS/PT) and risk of obstetric anti-phospholipid syndrome
    Zhang, Xiaoxin
    Liu, Zhilan
    Guo, Feng
    Wang, Qiaohong
    Bai, Wenxin
    Zhao, Aimin
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 89 (06)
  • [32] Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
    Zigon, Polona
    Pirkmajer, Katja Perdan
    Tomsic, Matija
    Kveder, Tanja
    Bozic, Borut
    Semrl, Snezna Sodin
    Cucnik, Sasa
    Ambrozic, Ales
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [33] Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies
    Martinez-Valle, Ferran
    Ordi-Ros, Josep
    Selva-O'Callaghan, Albert
    Balada, Eva
    Solans-Laque, Roser
    Vilardell-Tarres, Miquel
    MEDICINA CLINICA, 2009, 132 (20): : 767 - 771
  • [34] Factors related to the risk of thrombosis in patients with lupus antiphospholipid antibodies and
    Martinez, Fernando
    Forner, Maria Jose
    Ruano, Maria
    Abdilla, Noelia
    Oltra, Rosa
    Garcia-Fuster, Maria Jose
    MEDICINA CLINICA, 2006, 127 (11): : 405 - 408
  • [35] Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
    Egri, Natalia
    Bentow, Chelsea
    Rubio, Laura
    Norman, Gary L.
    Lopez-Sanudo, Susana
    Mahler, Michael
    Perez-Isidro, Albert
    Cervera, Ricard
    Vinas, Odette
    Espinosa, Gerard
    Ruiz-Ortiz, Estibaliz
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant
    Nojima, J
    Suehisa, E
    Akita, N
    Toku, M
    Fushimi, R
    Tada, H
    Kuratsune, H
    Machii, T
    Kitani, T
    Amino, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (03) : 447 - 450
  • [37] Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients
    Molino, D
    De Santo, NG
    Marotta, R
    Anastasio, P
    Mosavat, M
    De Lucia, D
    SEMINARS IN NEPHROLOGY, 2004, 24 (05) : 495 - 501
  • [38] Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus
    Martínez-Berriotxoa, A
    Ruiz-Irastorza, G
    Egrubide, MV
    Rueda, M
    Aguirre, C
    LUPUS, 2004, 13 (12) : 927 - 933
  • [39] Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies
    Simantov, R
    Lo, SK
    Salmon, JE
    Sammaritano, LR
    Silverstein, RL
    THROMBOSIS RESEARCH, 1996, 84 (05) : 361 - 365
  • [40] THE USE OF AN ANTI-BETA(2)-GLYCOPROTEIN-I ASSAY FOR DISCRIMINATION BETWEEN ANTICARDIOLIPIN ANTIBODIES ASSOCIATED WITH INFECTION AND INCREASED RISK OF THROMBOSIS
    MCNALLY, T
    PURDY, G
    MACKIE, IJ
    MACHIN, SJ
    ISENBERG, DA
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 471 - 473
12345